A detailed history of Ronald Blue Trust, Inc. transactions in Harvard Bioscience Inc stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 78 shares of HBIO stock, worth $162. This represents 0.0% of its overall portfolio holdings.

Number of Shares
78
Holding current value
$162
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$2.64 - $3.54 $205 - $276
78 New
78 $0
Q2 2022

Aug 09, 2022

BUY
$3.28 - $6.42 $118 - $231
36 New
36 $0

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $86.6M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track Ronald Blue Trust, Inc. Portfolio

Follow Ronald Blue Trust, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ronald Blue Trust, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ronald Blue Trust, Inc. with notifications on news.